Contact Us

The choice depends on whether you are studying ATG12's role as a ubiquitin-like protein in the ATG12-ATG5 conjugation system for autophagy or modeling autophagy deficiency. The Knockout line is the standard tool for asking whether ATG12 is required for canonical autophagy — ATG12 is a ubiquitin-like protein that is conjugated to ATG5 via ATG7 (E1)-ATG10 (E2) cascade, with the ATG12-ATG5 conjugate functioning as the E3-like ligase for LC3 lipidation; ATG12 is essential for canonical autophagy. Overexpression is useful for studying ATG12 gain-of-function effects. For autophagy research, the EDITGENE ATG12 Knockout in HAP1 is the gold-standard autophagy-deficient haploid cell model — ATG12 KO abolishes LC3-II formation and canonical macroautophagy. This product complements the parallel ATG7 Knockout in HEK293 (also available) for systematic autophagy machinery dissection. Rescue with wild-type or conjugation-deficient ATG12 (G140A C-terminal glycine for ATG5 conjugation) enables structure-function studies. The knockout is valuable for studying autophagy biology and emerging ATG12-related apoptosis regulation (an unusual autophagy-independent role of ATG12).

Yes. ATG12 rescue experiments are gold-standard for autophagy research: • Construct design: use a codon-modified ATG12 sequence with a small C-terminal tag — but note that ATG12 is conjugated to ATG5 via its C-terminal glycine (G140); C-terminal tags may interfere with conjugation. N-terminal tag is preferred. • Conjugation-deficient rescue: G140A mutation abolishes ATG5 conjugation — gold-standard specificity control. • Functional readout: rescue should restore ATG12-ATG5 conjugation and LC3-II formation. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying BMPR1B in the HAP1 haploid platform for systematic biochemical analyses. The Knockout line is the standard tool for asking whether BMPR1B is required for BMP signaling — BMPR1B is a type I BMP serine/threonine kinase receptor (see BMPR1B/HEK293 entry for detailed mechanism). Overexpression is useful for studying BMPR1B gain-of-function effects. Important consideration: BMPR1A (ALK3) paralog expression analysis aids interpretation given partial functional overlap. This product complements the parallel BMPR1B Knockout in HEK293 (also available) for systematic cross-background BMP signaling research. Rescue with wild-type or kinase-dead BMPR1B is the standard specificity control. The knockout is valuable for studying BMP type I receptor biology in HAP1's clean genetic background. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

Yes. BMPR1B rescue in HAP1 follows the same considerations as the HEK293 product: • Construct design: same considerations as BMPR1B/HEK293 rescue (kinase domain preservation, intracellular C-terminal tag). • Cross-background validation: parallel rescue in HAP1 and HEK293 confirms BMPR1B-specific phenotypes. • Functional readout: rescue should restore BMP-induced phospho-SMAD1/5/8. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying CSMD1 (CUB and Sushi multiple domains 1)'s role as a complement regulator or modeling schizophrenia susceptibility and cancer biology. The Knockout line is the standard tool for asking whether CSMD1 is required for these processes — CSMD1 is a large transmembrane protein with multiple extracellular CUB and sushi (complement control protein) domains, functioning as a regulator of the complement cascade by inhibiting C3 convertase activity; CSMD1 has emerged as one of the strongest schizophrenia GWAS-associated genes and has reported tumor suppressor functions. Overexpression is useful for studying CSMD1 in heterologous expression contexts. For psychiatric and cancer biology research, the EDITGENE CSMD1 Knockout in HAP1 enables study of CSMD1 biology. Rescue with wild-type CSMD1 (large gene — full-length cDNA rescue is technically challenging) is the standard specificity control. The knockout is valuable for studying complement regulation, schizophrenia GWAS susceptibility mechanisms (CSMD1 is among the top schizophrenia risk loci), and emerging CSMD1-related cancer biology.

Yes, with significant technical considerations for this very large protein: • Construct design: CSMD1 encodes a ~388 kDa transmembrane protein with multiple CUB and sushi domains from a >35 kb mRNA — full-length cDNA rescue is technically very challenging. Domain-focused rescue with key CUB/sushi domains may be more tractable. • Surface localization validation: confirm plasma membrane localization by cell surface staining before functional assays. • Complement regulation studies: rescue with WT CSMD1 should restore C3 convertase inhibition. • Functional readout: rescue should restore CSMD1-dependent phenotypes; technical complexity may require domain-fragment-based approaches. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying CSNK1E (casein kinase 1ε, CK1ε)'s role as a circadian rhythm regulator and Wnt pathway component or modeling sleep disorder pharmacology. The Knockout line is the standard tool for asking whether CK1ε is required for these processes — CK1ε is a serine/threonine kinase closely related to CSNK1D/CK1δ; CK1ε/δ phosphorylate PER1/PER2 (circadian rhythm period proteins) to control their stability and the molecular clock period; CK1ε/δ also participate in the Wnt destruction complex (β-catenin priming phosphorylation S45) and Hedgehog signaling. Overexpression is useful for studying CK1ε gain-of-function effects. Important consideration: CSNK1E and CSNK1D share substantial substrate scope — single CSNK1E knockout may show modest phenotypes if CK1δ compensates. Rescue with wild-type or kinase-dead CK1ε is the standard specificity control. The knockout is a critical specificity tool for CK1ε/δ inhibitors (PF-670462, PF-5006739, longdaysin) in circadian rhythm modulation drug development — CK1ε/δ inhibition extends circadian period (familial advanced sleep phase syndrome, FASPS, is caused by activating CK1δ mutations).

Yes. CSNK1E rescue experiments are well-established for circadian and Wnt research: • Construct design: use a codon-modified CSNK1E sequence with a small C-terminal tag (FLAG, HA). CK1ε has N-terminal kinase domain and C-terminal autoinhibitory tail — preserve all elements. • Kinase-dead rescue: K38R mutation in the ATP-binding lysine abolishes catalytic activity. • Autoinhibitory tail mutant rescue: C-terminal tail truncation removes autoinhibition, generating constitutively active CK1ε. • Functional readout: rescue should restore PER1/PER2 phosphorylation and degradation kinetics, and β-catenin S45 priming. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying BRCC3 (BRCA1/BRCA2-containing complex subunit 3, BRCC36)'s role as a K63-specific deubiquitinase or modeling its functions in BRCA1-A complex DNA damage response and NLRP3 inflammasome regulation. The Knockout line is the standard tool for asking whether BRCC3 is required for these processes — BRCC3 is a JAMM-family deubiquitinase that specifically cleaves K63-linked ubiquitin chains; BRCC3 functions in two major complexes: (1) the BRCA1-A complex (with BRCA1, BRCC36, ABRAXAS1, BRE, RAP80, NBA1) recruited to DNA damage sites; (2) the cytoplasmic BRISC complex (with ABRO1, BRE, NBA1) for NLRP3 inflammasome deubiquitination. Overexpression is useful for studying BRCC3 in heterologous expression contexts. For DNA repair and inflammasome research, the EDITGENE BRCC3 Knockout in HAP1 enables study of K63-specific deubiquitination biology. Rescue with wild-type or catalytically-dead BRCC3 (H122A in JAMM motif) enables structure-function studies. BRCC3 mutations have been characterized in moyamoya syndrome (intracranial vascular disease). The knockout is valuable for studying BRCA1-A complex biology, NLRP3 inflammasome regulation, and emerging BRCC3-targeted therapeutic approaches.

Yes. BRCC3 rescue experiments require attention to JAMM deubiquitinase architecture: • Construct design: use a codon-modified BRCC3 sequence with a small C-terminal tag (FLAG, HA). BRCC3 has JAMM/MPN+ domain with catalytic histidine — preserve all elements. • Catalytically-dead rescue: H122A mutation in the JAMM motif abolishes deubiquitinase activity. • BRISC vs BRCA1-A complex rescue: full-length BRCC3 reconstitutes both complexes; complex-specific rescue requires partner expression analysis. • Functional readout: rescue should restore K63-Ub chain processing and BRCA1-A complex IR-induced foci formation. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying CAMK2G (CaMKIIγ)'s role as a Ca²⁺/calmodulin-dependent kinase or modeling its functions in T cell signaling and cancer biology. The Knockout line is the standard tool for asking whether CAMK2G is required for these processes — CAMK2 family (CAMK2A, CAMK2B, CAMK2D, CAMK2G) are Ca²⁺/calmodulin-dependent serine/threonine kinases that assemble into 12-subunit holoenzymes with autonomous activity following Ca²⁺-induced T286/T287 autophosphorylation; CAMK2A and CAMK2B are dominant in neurons (synaptic plasticity, learning/memory), CAMK2D in cardiomyocytes (heart failure), CAMK2G in T cells and other contexts. Overexpression is useful for studying CAMK2G gain-of-function effects. Important consideration: CAMK2 family members share substantial substrate scope — single CAMK2G knockout may show modest phenotypes if other CAMK2s compensate. Rescue with wild-type, kinase-dead (K43R), or T287A (autonomy-deficient) CAMK2G enables structure-function studies. The knockout is valuable for studying CaMKII signaling biology and emerging CAMK2-targeted therapeutics (KN-93 historic CAMK2 inhibitor + new selective compounds).

Yes. CAMK2G rescue experiments require attention to CaMKII holoenzyme architecture: • Construct design: use a codon-modified CAMK2G sequence with a small C-terminal tag (FLAG, HA). CAMK2G has N-terminal kinase domain (with T287 autophosphorylation site, autonomy switch) and C-terminal association domain (12-subunit holoenzyme assembly) — preserve all elements. • Kinase-dead rescue: K43R mutation in the ATP-binding lysine abolishes catalytic activity. • Autonomy-deficient rescue: T287A mutation abolishes Ca²⁺-independent autonomous activity, generating Ca²⁺-only-dependent CAMK2G. • Constitutively active rescue: T287D phospho-mimetic mutation generates constitutively autonomous CAMK2G. • Functional readout: rescue should restore Ca²⁺/calmodulin-dependent substrate phosphorylation. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying BRD1's role as the principal histone H4 acetyltransferase complex scaffold or modeling its emerging functions in hematologic biology. The Knockout line is the standard tool for asking whether BRD1 is required for these processes — BRD1 (BRPF2) is a bromodomain-containing protein that scaffolds the BRD1-HBO1 (KAT7/MYST2)-MEAF6-ING5 histone acetyltransferase complex, deposing the H4K12ac mark on chromatin; BRD1 is critical for proper hematopoiesis and has reported emerging functions in psychiatric disease GWAS. Overexpression is useful for studying BRD1 in heterologous expression contexts. For histone acetyltransferase research, the EDITGENE BRD1 Knockout in HAP1 enables study of HBO1 complex biology. Other bromodomain family member expression analysis aids interpretation. Rescue with wild-type or bromodomain-mutant BRD1 enables structure-function studies. The knockout is valuable for studying H4K12ac deposition, HBO1 complex biology, and emerging BRD1/HBO1-targeted approaches (HBO1 inhibitors WM-1119 in preclinical development for AML).

Yes. BRD1 rescue experiments require attention to HBO1 complex assembly: • Construct design: use a codon-modified BRD1 sequence with a small C-terminal tag (FLAG, HA). BRD1 has PWWP, bromodomain, and zinc finger domains — preserve all elements. • Bromodomain-mutant rescue: BRD acetyl-mark recognition pocket mutations. • HBO1 complex assembly: rescue interpretation considers HBO1 (KAT7/MYST2), MEAF6, ING5 expression. • Functional readout: rescue should restore H4K12ac deposition. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying CCR6 (CC chemokine receptor 6)'s role as the principal Th17 and B-cell chemokine receptor or modeling its functions in inflammatory disease and hepatic biology. The Knockout line is the standard tool for asking whether CCR6 is required for these processes — CCR6 is a Gαi-coupled seven-transmembrane GPCR uniquely activated by CCL20/MIP-3α (and human β-defensins as alternative ligands), with predominant expression on Th17 cells, regulatory T cells (Tregs), B cells, and dendritic cells; CCR6 mediates mucosal homing especially to gut and skin. Overexpression is useful for studying CCR6 in heterologous expression contexts. For hepatic inflammation and IBD research, the EDITGENE CCR6 Knockout in Hep-G2 is relevant — Hep-G2 provides a hepatocellular context, and CCR6-CCL20 has been characterized in liver disease and inflammatory bowel disease pathology. Rescue with wild-type or signaling-deficient CCR6 enables structure-function studies. The knockout is a critical specificity tool for emerging CCR6 antagonists (CCX507 in clinical development for ulcerative colitis, PF-07054894, vidofludimus calcium with CCR6 effects) and CCR6-targeted approaches in psoriasis, IBD, and rheumatoid arthritis.